Nonrandomized Comparison of Adverse Events Following Facility- and Home-Infused Biologics Using Real-World Data

JAMA Netw Open. 2021 Jun 1;4(6):e2111156. doi: 10.1001/jamanetworkopen.2021.11156.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • Arthritis, Rheumatoid* / drug therapy
  • Biological Products* / adverse effects
  • Humans

Substances

  • Antirheumatic Agents
  • Biological Products